Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?

Accepted for/Published in: JMIR Research Protocols

Date Submitted: Mar 3, 2024
Open Peer Review Period: Mar 3, 2024 - Apr 28, 2024
Date Accepted: Oct 16, 2024
(closed for review but you can still tweet)

The final, peer-reviewed published version of this preprint can be found here:

Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial

da Rosa ALST, da Costa MRB, Sorato G, Manjabosco F, de Bem ÃB, Dellazari L, Falcão AB, Cia LdO, Bezerra OS, Borges RB, Rohde LAP, Graeff-Martins AS

Clozapine for Treatment-Resistant Disruptive Behaviors in Youths With Autism Spectrum Disorder Aged 10-17 Years: Protocol for an Open-Label Trial

JMIR Res Protoc 2025;14:e58031

DOI: 10.2196/58031

PMID: 39883920

PMCID: 11826951

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Per the author's request this version is not available.